Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verlinde

Showing results (71-80 of 252) with videos related to

Pageof 26
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIARob C Oslund, Nathan Cermak, Christophe L M J Verlinde, et al.
Journal of Medicinal Chemistry|August 19, 2005
The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas diseaseOliver Hucke, Michael H Gelb, Christophe L M J Verlinde, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|December 15, 1989
Structure and absolute configuration of two stereoisomers of alpha,alpha'-[iminobis-(methylene)]bis(3,4-dihydro-2H-1-benzopyran-2- methanol) hydrobromideO M Peeters, C L Verlinde, N M Blaton, et al.
Acta Chirurgica Belgica|May 16, 2025
Adrenal cortical carcinoma - a case series and literature review of aggressive adrenal incidentalomasLiesbeth Verlinde, Sam Kinet, Klaas Van Den Heede, et al.
Fertility and Sterility|April 7, 2004
Number of ovarian follicles in human fetuses with the 45,X karyotypeKarine Reynaud, Rita Cortvrindt, Franciska Verlinde, et al.
Perception|January 1, 1994
A transparent motion aftereffect contingent on binocular disparityF A Verstraten, R Verlinde, R E Fredericksen, et al.
PDA Journal of Pharmaceutical Science and Technology|August 20, 2025
Charting the Universe of Organic Extractables and Leachables Compounds with Confirmed identitiesDennis Jenke, Piet Christiaens, Adam Jenke, et al.
The Journal of Biological Chemistry|November 24, 1999
Using a galactose library for exploration of a novel hydrophobic pocket in the receptor binding site of the Escherichia coli heat-labile enterotoxinW E Minke, F Hong, C L Verlinde, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 15, 1989
Structure and conformational analysis of the opioid antagonist (-)-(1R,5R,9R)-5,9-diethyl-2-(3-furylmethyl)-2'-hydroxy-6,7-benzomorpha n (Mr2266)C L Verlinde, N M Blaton, O M Peeters, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|May 15, 1989
Structure of a kappa-opioid receptor misfit: (1S,5R,8R,9R)-2'-hydroxy-5,9-dimethyl-8,2-epoxyethano-6,7-benzomorphan hydrochlorideC L Verlinde, N M Blaton, C J De Ranter, et al.
Pageof 26

Showing results (71-80 of 252) with videos related to

Sort By:
Pageof 26
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIARob C Oslund, Nathan Cermak, Christophe L M J Verlinde, et al.
Journal of Medicinal Chemistry|August 19, 2005
The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas diseaseOliver Hucke, Michael H Gelb, Christophe L M J Verlinde, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|December 15, 1989
Structure and absolute configuration of two stereoisomers of alpha,alpha'-[iminobis-(methylene)]bis(3,4-dihydro-2H-1-benzopyran-2- methanol) hydrobromideO M Peeters, C L Verlinde, N M Blaton, et al.
Acta Chirurgica Belgica|May 16, 2025
Adrenal cortical carcinoma - a case series and literature review of aggressive adrenal incidentalomasLiesbeth Verlinde, Sam Kinet, Klaas Van Den Heede, et al.
Fertility and Sterility|April 7, 2004
Number of ovarian follicles in human fetuses with the 45,X karyotypeKarine Reynaud, Rita Cortvrindt, Franciska Verlinde, et al.
Perception|January 1, 1994
A transparent motion aftereffect contingent on binocular disparityF A Verstraten, R Verlinde, R E Fredericksen, et al.
PDA Journal of Pharmaceutical Science and Technology|August 20, 2025
Charting the Universe of Organic Extractables and Leachables Compounds with Confirmed identitiesDennis Jenke, Piet Christiaens, Adam Jenke, et al.
The Journal of Biological Chemistry|November 24, 1999
Using a galactose library for exploration of a novel hydrophobic pocket in the receptor binding site of the Escherichia coli heat-labile enterotoxinW E Minke, F Hong, C L Verlinde, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 15, 1989
Structure and conformational analysis of the opioid antagonist (-)-(1R,5R,9R)-5,9-diethyl-2-(3-furylmethyl)-2'-hydroxy-6,7-benzomorpha n (Mr2266)C L Verlinde, N M Blaton, O M Peeters, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|May 15, 1989
Structure of a kappa-opioid receptor misfit: (1S,5R,8R,9R)-2'-hydroxy-5,9-dimethyl-8,2-epoxyethano-6,7-benzomorphan hydrochlorideC L Verlinde, N M Blaton, C J De Ranter, et al.
Pageof 26